GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 19th Apr 2024 ABUS stock ended at $2.72. This is 0.366% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 6.04% from a day low at $2.65 to a day high of $2.81.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2021-01-06 $3.56 $3.78 $3.51 $3.57 2 642 083
2021-01-05 $3.57 $3.67 $3.54 $3.55 1 373 310
2021-01-04 $3.52 $3.66 $3.43 $3.64 1 804 657
2020-12-31 $3.72 $3.73 $3.49 $3.55 2 600 525
2020-12-30 $3.56 $3.72 $3.50 $3.72 2 304 845
2020-12-29 $3.68 $3.69 $3.47 $3.50 2 887 577
2020-12-28 $3.86 $3.87 $3.61 $3.63 3 886 690
2020-12-24 $4.04 $4.05 $3.75 $3.87 2 875 434
2020-12-23 $3.97 $4.18 $3.86 $4.05 2 729 416
2020-12-22 $4.11 $4.22 $3.83 $4.04 5 889 468
2020-12-21 $4.25 $4.37 $4.02 $4.25 4 840 501
2020-12-18 $4.83 $4.85 $4.35 $4.35 6 389 793
2020-12-17 $5.08 $5.08 $4.47 $4.73 7 647 837
2020-12-16 $4.94 $4.95 $4.30 $4.41 6 543 282
2020-12-15 $5.08 $5.87 $4.66 $4.97 24 287 702
2020-12-14 $4.08 $5.23 $3.91 $4.88 19 601 978
2020-12-11 $3.80 $3.99 $3.62 $3.91 4 156 168
2020-12-10 $3.59 $3.72 $3.51 $3.67 3 077 490
2020-12-09 $3.77 $3.79 $3.40 $3.41 3 433 370
2020-12-08 $3.95 $3.95 $3.77 $3.79 2 040 052
2020-12-07 $4.03 $4.03 $3.84 $3.95 1 386 010
2020-12-04 $3.98 $4.06 $3.78 $4.01 2 133 285
2020-12-03 $4.03 $4.09 $3.91 $3.94 2 118 197
2020-12-02 $4.08 $4.10 $3.88 $3.95 3 092 894
2020-12-01 $4.84 $4.90 $3.99 $3.99 6 459 042
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT